An open label, randomized, comparative, parallel group, multicenter, prospective, interventional, clinical study to evaluate efficacy and safety of “AHPL/AYTOP/0113” in comparison with “Framycetin sulphate cream” in acute wounds

SanjayU Nipanikar; KamalakarV Gajare; VidyadharG Vaidya; AmolB Kamthe; SachinA Upasani; VidyadharS Kumbhar

doi:10.4103/asl.asl_52_16

An open label, randomized, comparative, parallel group, multicenter, prospective, interventional, clinical study to evaluate efficacy and safety of “AHPL/AYTOP/0113” in comparison with “Framycetin sulphate cream” in acute wounds

Ancient Science of Life ◽

10.4103/asl.asl_52_16 ◽

2017 ◽

Vol 36 (3) ◽

pp. 117 ◽

Cited By ~ 1

Author(s):

SanjayU Nipanikar ◽

KamalakarV Gajare ◽

VidyadharG Vaidya ◽

AmolB Kamthe ◽

SachinA Upasani ◽

...

Keyword(s):

Clinical Study ◽

Efficacy And Safety ◽

Open Label ◽

Parallel Group

Download Full-text

A Randomized, Open-label, Parallel-group Clinical Study to Evaluate the Efficacy and Safety of Omalizumab in the Treatment of Persistent Moderate and Severe Allergic Asthma and Persistent Allergic Rhinitis in Pediatric Patients 6 to 17 years of age

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2018.12.288 ◽

2019 ◽

Vol 143 (2) ◽

pp. AB94

Author(s):

Socorro Orozco Martinez ◽

Alvaro Pedroza-Meléndez ◽

Vania Trejo-Uribe ◽

Sandra Bautista-García ◽

Alberto Contreras-Verduzco ◽

...

Keyword(s):

Allergic Rhinitis ◽

Clinical Study ◽

Allergic Asthma ◽

Pediatric Patients ◽

Efficacy And Safety ◽

Open Label ◽

Persistent Allergic Rhinitis ◽

Parallel Group ◽

Severe Allergic Asthma

Download Full-text

Evaluation of Efficacy and Safety of ‘AHPL/AYTOP/2014A’ in Patients Suffering from Aphthous Ulcers - An Open Label, Randomized, Multi-center, Prospective, Active Controlled, Parallel Group, Clinical Study

International Journal of Pharmaceutical Investigation ◽

10.5530/ijpi.2021.2.42 ◽

2021 ◽

Vol 11 (2) ◽

pp. 238-243

Author(s):

Sanjay Nipanikar ◽

Narendra Mundhe ◽

Vaishali Deshpande ◽

Nitin Shinde ◽

Mangesh Wakchaoure ◽

...

Keyword(s):

Clinical Study ◽

Efficacy And Safety ◽

Open Label ◽

Aphthous Ulcers ◽

Parallel Group

Download Full-text

A Phase II, Randomized, Open-Label, Parallel-Group Study to Evaluate the Efficacy and Safety of Autologous Dendritic Cell Vaccination (ADCV01) as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients

Case Medical Research ◽

10.31525/ct1-nct04115761 ◽

2019 ◽

Author(s):

Keyword(s):

Dendritic Cell ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

Dendritic Cell Vaccination ◽

Efficacy And Safety ◽

Autologous Dendritic Cell ◽

Open Label ◽

Primary Glioblastoma ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

180 An open-label randomized active-controlled phase ii clinical study to assess efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer

10.1136/ijgc-2020-igcs.157 ◽

2020 ◽

Author(s):

Y Yue ◽

H Shen ◽

C Lu ◽

BN Hughes ◽

RL Coleman ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Study ◽

Phase Ii ◽

Efficacy And Safety ◽

Open Label ◽

Platinum Resistant ◽

Phase Ii Clinical Study

Download Full-text

Efficacy and Safety of a New Topical Hair Loss-Lotion Containing Oleanolic Acid, Apigenin, Biotinyl Tripeptide-1, Diaminopyrimidine Oxide, Adenosine, Biotin and Ginkgo biloba in Patients with Androgenetic Alopecia and Telogen effluvium: A Six-month Open-Label Prospective Clinical Study

Journal of Cosmetology & Trichology ◽

10.4172/2471-9323.1000132 ◽

2018 ◽

Vol 04 (01) ◽

Author(s):

Aurora Garre ◽

Jaime Piquero ◽

Carles Trullas ◽

Gemma Martinez

Keyword(s):

Clinical Study ◽

Oleanolic Acid ◽

Hair Loss ◽

Ginkgo Biloba ◽

Androgenetic Alopecia ◽

Prospective Clinical Study ◽

Efficacy And Safety ◽

Open Label

Download Full-text

Long-term efficacy and safety of agomelatine in non-depressed out-patients with generalized anxiety disorder. A 26-week randomised double-blind placebo-controlled parallel group study following an open-label period of 16 weeks with agomelatine (25 mg/day with the possibility for blinded dose-adjustment to 50 mg/day)

http://isrctn.org/> ◽

10.1186/isrctn38094599 ◽

2012 ◽

Author(s):

Istvan Bitter

Keyword(s):

Anxiety Disorder ◽

Generalized Anxiety Disorder ◽

Dose Adjustment ◽

Generalized Anxiety ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive breast cancer: a phase III, randomized, open-label, parallel-group comparative study

Breast Cancer ◽

10.1007/s12282-016-0691-6 ◽

2016 ◽

Vol 24 (1) ◽

pp. 161-170 ◽

Cited By ~ 5

Author(s):

Junichi Kurebayashi ◽

Tatsuya Toyama ◽

Shuuji Sumino ◽

Eri Miyajima ◽

Tsukasa Fujimoto

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Leuprorelin Acetate ◽

Hormone Receptor Positive ◽

Parallel Group ◽

Premenopausal Patients ◽

Positive Breast Cancer

Download Full-text

Evaluation of the Efficacy and Safety of Hyaluronic Acid Vaginal Gel to Ease Vaginal Dryness: A Multicenter, Randomized, Controlled, Open‐Label, Parallel‐Group, Clinical Trial

Journal of Sexual Medicine ◽

10.1111/jsm.12125 ◽

2013 ◽

Vol 10 (6) ◽

pp. 1575-1584 ◽

Cited By ~ 60

Author(s):

Junya Chen ◽

Li Geng ◽

Xuehong Song ◽

Hongxia Li ◽

Nicola Giordan ◽

...

Keyword(s):

Clinical Trial ◽

Hyaluronic Acid ◽

Efficacy And Safety ◽

Open Label ◽

Vaginal Dryness ◽

Randomized Controlled ◽

Vaginal Gel ◽

Parallel Group

Download Full-text

P057: Efficacy and safety of Peginterferon alfa-2b (40 kD, Y Shape) (Pegberon) in HBeAg- positive CHB patients - a phase III, randomized, multicenter, positive-controlled, open-label clinical study

Journal of Viral Hepatitis ◽

10.1111/jvh.54_12425 ◽

2015 ◽

Vol 22 ◽

pp. 48-48

Keyword(s):

Clinical Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Peginterferon Alfa

Download Full-text

The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study

Journal of Obstetrics and Gynaecology Research ◽

10.1111/jog.13807 ◽

2018 ◽

Vol 45 (1) ◽

pp. 168-175

Author(s):

Fuminori Taniguchi ◽

Ikuko Ota ◽

Yumiko Iba ◽

Toshiko Toda ◽

Yukiko Tagashira ◽

...

Keyword(s):

Clinical Study ◽

Efficacy And Safety ◽

Open Label ◽

Multicenter Clinical Study

Download Full-text